Related Experiment Video
Updated: Jul 18, 2026
07:34
Establishment of a Modified Ferric Chloride-Induced Superior Sagittal Sinus Thrombosis
Published on: December 30, 2025
Superior sagittal sinus thrombosis: a clinical and experimental study
Skull Base Surgery
|December 16, 2006
Summary
Superior sagittal sinus thrombosis (SSST) is a serious neurological condition. Early detection and treatment, especially with anticoagulants like heparin and urokinase, are vital for preventing brain damage, particularly when thrombosis extends into cortical veins.
Area of Science:
- Neurology
- Vascular Neurology
- Neuroscience
Background:
- Sinus-vein thrombosis, particularly superior sagittal sinus thrombosis (SSST), is a more common neurological disorder than previously understood.
- Understanding the pathophysiology of SSST is crucial for improving patient outcomes.
Purpose of the Study:
- To investigate the pathophysiology of superior sagittal sinus thrombosis (SSST) using both human patient data and an animal model.
- To identify factors associated with poor outcomes in SSST patients.
- To evaluate the impact of thrombosis extension on cerebral blood flow and brain injury.
Main Methods:
- Analysis of 19 patients diagnosed with SSST via angiography.
- Development and utilization of a rat model to induce SSST.
- Measurement of regional cerebral blood flow (rCBF) and tissue hemoglobin oxygen saturation (Hb SO2) in rats.
- Histological examination of brain tissue in the animal model.
Main Results:
- Female sex, sudden onset of symptoms (<24 hours), and posterior 1/3 sinus occlusion were linked to adverse outcomes in patients.
- In the rat model, extension of thrombosis from the superior sagittal sinus into cortical veins led to decreased rCBF, reduced tissue Hb SO2, and observable brain damage.
- SSST confined to the sinus without cortical vein involvement did not result in brain injury in the animal model.
Conclusions:
- Acute extension of SSST into cortical veins critically impairs cerebral blood supply and metabolism.
- Cerebral blood flow (CBF), tissue Hb SO2, and repeated angiography are valuable tools for monitoring critical conditions post-SSST.
- Early intervention with anticoagulants (heparin and urokinase) is recommended for SSST cases without intracerebral hemorrhage to prevent thrombus progression and protect the brain.
Related Concept Videos
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
01:21Aneurysm II: Clinical Manifestations and Diagnostic Studies
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...